Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 10, 2010 - Issue 8
Submit an article Journal homepage
288
Views
70
CrossRef citations to date
0
Altmetric
Review

Ovarian cancer biomarkers for molecular biosensors and translational medicine

K Stephen Suh Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA;[email protected]
,
Sang W Park Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA
,
Angelica Castro Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA
,
Hiren Patel Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA
,
Patrick Blake Sophic Systems Alliance, Inc, Rockville, MD 20850, USA
,
Michael Liang Sophic Systems Alliance, Inc, Rockville, MD 20850, USA
&
Andre Goy Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA; Clinical Cancer Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA; Tissue Bank & Cancer Research Program, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA; Clinical Cancer Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA
 show all
Pages 1069-1083 | Published online: 09 Jan 2014

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xi Zhang, Benjamin L. Schulz & Chamindie Punyadeera. (2016) The current status of heart failure diagnostic biomarkers. Expert Review of Molecular Diagnostics 16:4, pages 487-500.
Read now
Byung-Joon Park, Mee-Kyung Cha & Il-Han Kim. (2014) Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses. Biomarkers 19:7, pages 604-610.
Read now

Articles from other publishers (68)

Kumari Binita Chandra, Anil Kumar Tomar, Ayushi Thapliyal, Jai Bhagwan Sharma, Neerja Bhatla & Savita Yadav. (2023) Differential proteomics reveals overexpression of ferroptosis-related proteins in cervical cancer tissue. Journal of Proteins and Proteomics.
Crossref
Zhao Liu, Chen Zhang, Beiming Cui, Yijie Wang, Kaisheng Lim, Kai Li, Jean Paul Thiery, Jun Chen & Chun Loong Ho. (2023) Targeted EpCAM-binding for the development of potent and effective anticancer proteins. Biomedicine & Pharmacotherapy 161, pages 114443.
Crossref
Shayon Mahalanobis, Apoorva, Nikita Sharma, Ritika Luthra, Tarunya Menon & Asmita Das. 2022. Microbial Crosstalk with Immune System. Microbial Crosstalk with Immune System 75 144 .
San-Gang Wu, Ping Zhou, Jian-Xian Chen, Jian Lei, Li Hua, Yong Dong, Min Hu, Chen-Lu Lian, Li-Chao Yang & Juan Zhou. (2021) circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell International 21:1.
Crossref
Valentina Rangel-Angarita & Stacy A. Malaker. (2021) Mucinomics as the Next Frontier of Mass Spectrometry. ACS Chemical Biology 16:10, pages 1866-1883.
Crossref
Shruti Sounkaria & Prakash Chandra. (2021) Ovarian Cancer: Potential biomarkers and nanotechnology based diagnostic tools. Advances in Natural Sciences: Nanoscience and Nanotechnology 12:3, pages 033001.
Crossref
Shahzadi Noreen, Safa Akhtar, Tahira Batool, Qurratulann Afza Gardner & Muhammad Waheed Akhtar. (2021) Tubulin Beta 2C Chain (TBB2C), a Potential Marker of Ovarian Cancer, an Insight from Ovarian Cancer Proteome Profile. ACS Omega 6:16, pages 10506-10514.
Crossref
Takayo UENO, Nobuko MATSUSHIMA, Hirotaka ANDO, Masataka KATASHIMA, Kumi MATSUNO & Yasuhiko IMAI. (2020) Current Status and Future Prospects of Biomarker Strategy for Drug Development医薬品開発におけるバイオマーカー戦略の現状と展望. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 51:3, pages 151-160.
Crossref
O. V., Pereginya. (2020) TRANSLATION MEDICINE, BIOMEDICINE AND MEDICAL BIOTECHNOLOGY: THE TRANSITION TO PERSONALIZED MEDICINE. Biotechnologia Acta 13:2, pages 5-11.
Crossref
Angela Bauch, Johann Pellet, Tina Schleicher, Xiao Yu, Andrea Gelemanović, Cosimo Cristella, Pieter L. Fraaij, Ozren Polasek, Charles Auffray, Dieter Maier, Marion Koopmans & Menno D. de Jong. (2020) Informing epidemic (research) responses in a timely fashion by knowledge management - a Zika virus use case. Biology Open.
Crossref
Juan Wang, Aijia Wu, Bingqing Yang, Xiaolu Zhu, Yincheng Teng & Zhihong Ai. (2020) Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer. Gene 724, pages 144150.
Crossref
Gottipati Geya & Kantharaju Supriya. (2018) Maternal Serum Cancer Antigen 125: A Marker of Severity of Preeclampsia. Journal of South Asian Federation of Obstetrics and Gynaecology 11:3, pages 153-155.
Crossref
Agni Pantou, Mara Simopoulou, Konstantinos Sfakianoudis, Polina Giannelou, Anna Rapani, Evangelos Maziotis, Sokratis Grigoriadis, Petroula Tsioulou, Stephen Syrkos, Kyriakos Souretis, Michael Koutsilieris & Konstantinos Pantos. (2019) The Role of Laparoscopic Investigation in Enabling Natural Conception and Avoiding in vitro Fertilization Overuse for Infertile Patients of Unidentified Aetiology and Recurrent Implantation Failure Following in vitro Fertilization. Journal of Clinical Medicine 8:4, pages 548.
Crossref
Stacy A. Malaker, Kayvon Pedram, Michael J. FerracaneBarbara A. BensingVenkatesh KrishnanChristian PettJin YuElliot C. WoodsJessica R. KramerUlrika WesterlindOliver DorigoCarolyn R. Bertozzi. (2019) The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proceedings of the National Academy of Sciences 116:15, pages 7278-7287.
Crossref
Gottipati Geya & Kantharaju Supriya. (2019) Maternal Serum Cancer Antigen 125: A Marker of Severity of Preeclampsia. Journal of South Asian Federation of Obstetrics and Gynaecology 11:2, pages 100-102.
Crossref
Vahideh Tarhriz, Mojgan Bandehpour, Siavoush Dastmalchi, Elaheh Ouladsahebmadarek, Habib Zarredar & Shirin Eyvazi. (2018) Overview of CD24 as a new molecular marker in ovarian cancer. Journal of Cellular Physiology 234:3, pages 2134-2142.
Crossref
Xiaoling Zhuge, Chuangen Guo, Yu Chen, Limin Feng, Rongfei Jia, Ying Zhao, Ke Sun, Zhongqiu Wang & Xiao Chen. (2018) The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma. Pancreas 47:10, pages 1290-1295.
Crossref
Mohammad Hasanzadeh, Rahimeh Sahmani, Elham Solhi, Ahad Mokhtarzadeh, Nasrin Shadjou & Soltanali Mahboob. (2018) Ultrasensitive immunoassay of carcinoma antigen 125 in untreated human plasma samples using gold nanoparticles with flower like morphology: A new platform in early stage diagnosis of ovarian cancer and efficient management. International Journal of Biological Macromolecules 119, pages 913-925.
Crossref
Meera Nair, Sardul Singh Sandhu & Anil Kumar Sharma. (2018) Cancer molecular markers: A guide to cancer detection and management. Seminars in Cancer Biology 52, pages 39-55.
Crossref
Vinayakumar Gedi, Chung Kil Song, Gae Baik Kim, Jin Oh Lee, Eunkyul Oh, Bum Seok Shin, Mingi Jung, Jinhee Shim, Haiwon Lee & Young-Pil Kim. (2018) Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform. Sensors and Actuators B: Chemical 256, pages 89-97.
Crossref
Emrys Scott-Murrell, David Lanza & Michael J. Schertzer. (2016) Dimensionless model for impedimetric sensing of particle laden droplets in digital microfluidic devices. Microsystem Technologies 23:8, pages 3131-3139.
Crossref
Bhuvan Molparia, Eshaan Nichani & Ali Torkamani. (2017) Assessment of circulating copy number variant detection for cancer screening. PLOS ONE 12:7, pages e0180647.
Crossref
Bi Wang, Lei Yu, Xin Luo, Lin Huang, Qin-Shan Li, Xiao-Shan Shao, Yi Liu, Yu Fan & Guo-Zhen Yang. (2017) Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer. Oncology Letters 14:1, pages 217-223.
Crossref
Michael Kleemann, Jeremias Bereuther, Simon Fischer, Kim Marquart, Simon Hänle, Kristian Unger, Verena Jendrossek, Christian U. Riedel, René Handrick & Kerstin Otte. (2016) Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis. Oncotarget 8:12, pages 18773-18791.
Crossref
Nathalie Swier & Henri H Versteeg. (2017) Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression. Thrombosis Research 150, pages 8-18.
Crossref
Ayala Tamir, Anju Gangadharan, Sakshi Balwani, Takemi Tanaka, Ushma Patel, Ahmed Hassan, Stephanie Benke, Agnieszka Agas, Joseph D’Agostino, Dayoung Shin, Sunghoon Yoon, Andre Goy, Andrew Pecora & K. Stephen Suh. (2016) The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer. Journal of Ovarian Research 9:1.
Crossref
Jung Min Lee, Hwan Hee Lee, Sohyun Park, Tae Sung Kim & Seok-Ki Kim. (2016) Random Assay in Radioimmunoassay: Feasibility and Application Compared with Batch Assay. Nuclear Medicine and Molecular Imaging 50:4, pages 337-343.
Crossref
David Gomez-Cabrero, Jörg Menche, Claudia Vargas, Isaac Cano, Dieter Maier, Albert-László Barabási, Jesper Tegnér & Josep Roca. (2016) From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration. BMC Bioinformatics 17:S15.
Crossref
Hossam H. El Sokkary & Reham Abdel Haleem. (2016) Studying CA-125 tumor marker level in different stages, histopathological types, and grades of endometrial cancer. Evidence Based Womenʼs Health Journal 6:4, pages 149-152.
Crossref
Noriaki Arakawa, Hiroshi Kobayashi, Naohiro Yonemoto, Yusuke Masuishi, Yoko Ino, Hiroshi Shigetomi, Naoto Furukawa, Norihisa Ohtake, Yohei Miyagi, Fumiki Hirahara, Hisashi Hirano & Etsuko Miyagi. (2016) Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma. PLOS ONE 11:10, pages e0165609.
Crossref
Hui Zhao, Guanfeng Lin, Tiancai Liu, Junyu Liang, Zhiqi Ren, Rongliang Liang, Baihong Chen, Wenhua Huang & Yingsong Wu. (2016) Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA). Journal of Immunological Methods 437, pages 64-69.
Crossref
Arun V. Everest-Dass, Matthew T. Briggs, Gurjeet Kaur, Martin K. Oehler, Peter Hoffmann & Nicolle H. Packer. (2016) N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues. Molecular & Cellular Proteomics 15:9, pages 3003-3016.
Crossref
Shikha Sharma, Ragini Raghav, Richard O’Kennedy & Sudha Srivastava. (2016) Advances in ovarian cancer diagnosis: A journey from immunoassays to immunosensors. Enzyme and Microbial Technology 89, pages 15-30.
Crossref
Yu-Li Chen, Cheng-Yang Chou, Ming-Cheng Chang, Han-Wei Lin, Ching-Ting Huang, Shu-Feng Hsieh, Chi-An Chen & Wen-Fang Cheng. (2015) IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients. Endocrine-Related Cancer 22:5, pages 703-711.
Crossref
Samar Masoumi-Moghaddam, Afshin Amini, Ai-Qun Wei, Gregory Robertson & David L. Morris. (2015) Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer. Oncotarget 6:29, pages 28491-28501.
Crossref
Ramesh G, Sandeep Kumar S, Shalini N. Swamy, Premalata C S & Pallavi V R. (2015) A STUDY ON THE ABERRANT PROMOTER HYPERMETHYLATION OF RAR - β GENE IN THE PLASMA OF EPITHELIAL OVARIAN CARCINOMA PATIENTS. Journal of Evidence Based Medicine and Healthcare 2:21, pages 3111-3118.
Crossref
Panagiotis Peitsidis. 2015. Noninvasive Molecular Markers in Gynecologic Cancers. Noninvasive Molecular Markers in Gynecologic Cancers 413 436 .
Sharon O’Toole, Eugen Ancuta, Ream Langhe, MB CHB, Dolores Cahill, Mairead Murphy, Cara Martin, Lynda McEvoy, Cathy Spillane, Orla Sheils, Emmanuel Petricoin, Lance Liotta & John O’Leary. 2015. Noninvasive Molecular Markers in Gynecologic Cancers. Noninvasive Molecular Markers in Gynecologic Cancers 303 336 .
Aarti N. Desai & Abhay Jere. 2015. Next Generation Sequencing in Cancer Research, Volume 2. Next Generation Sequencing in Cancer Research, Volume 2 103 125 .
Ayala Tamir, Ushma Jag, Sreeja Sarojini, Craig Schindewolf, Takemi Tanaka, Rajendra Gharbaran, Hiren Patel, Anil Sood, Wei Hu, Ruzeen Patwa, Patrick Blake, Polina Chirina, Jin Oh Jeong, Heejin Lim, Andre Goy, Andrew Pecora & K Stephen Suh. (2014) Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. Journal of Ovarian Research 7:1.
Crossref
Theresa L Wellman, Midori Eckenstein, Cheung Wong, Mercedes Rincon, Takamaru Ashikaga, Sharon L Mount, Christopher S Francklyn & Karen M Lounsbury. (2014) Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. BMC Cancer 14:1.
Crossref
Zhihua Liu, Liang Kang, Meijin Huang, Chao Li, Chao Tong, Xingwei Zhang, Lei Wang & Jianping Wang. (2014) No advantages of laparoscopy for left-sided malignant colonic obstruction compared with open colorectal resection in both short-term and long-term outcomes. Medical Oncology 31:10.
Crossref
Chhunthang Thanpari, Naval Kishor Yadav, Roshan Takhelmayum, Mukesh Kumar Shrewastwa, Rabindra Kumar Mittal & Priyanka Thapa. (2014) Evaluation of CA-125 and other biochemical parameters in premenopausal and postmenopausal women with ovarian cancer: a hospital based study from Western Nepal. Asian Pacific Journal of Tropical Disease 4, pages S717-S719.
Crossref
YANHONG LI, LI YAO, FEI LIU, JIA HONG, LIN CHEN, BEILEI ZHANG & WEI ZHANG. (2014) Characterization of microRNA expression in serous ovarian carcinoma. International Journal of Molecular Medicine 34:2, pages 491-498.
Crossref
Yeon Kyung Lee, Kyeong-Seok Lee, Won Mok Kim & Young-Soo Sohn. (2014) Detection of Amyloid-β42 Using a Waveguide-Coupled Bimetallic Surface Plasmon Resonance Sensor Chip in the Intensity Measurement Mode. PLoS ONE 9:6, pages e98992.
Crossref
Yingying MaZeyu SunRicardo de MatosJing ZhangKunle OdunsiBiaoyang Lin. (2014) Towards an Animal Model of Ovarian Cancer: Cataloging Chicken Blood Proteins Using Combinatorial Peptide Ligand Libraries Coupled with Shotgun Proteomic Analysis for Translational Research. OMICS: A Journal of Integrative Biology 18:5, pages 280-297.
Crossref
Gemma L. Owens, Ketan Gajjar, Júlio Trevisan, Simon W. Fogarty, Siân E. Taylor, Bianca Da Gama-Rose, Pierre L. Martin-Hirsch & Francis L. Martin. (2014) Vibrational biospectroscopy coupled with multivariate analysis extracts potentially diagnostic features in blood plasma/serum of ovarian cancer patients. Journal of Biophotonics 7:3-4, pages 200-209.
Crossref
Morten Muhlig Nielsen, Disa Tehler, Søren Vang, Frantisek Sudzina, Jakob Hedegaard, Iver Nordentoft, Torben Falck Ørntoft, Anders H. Lund & Jakob Skou Pedersen. (2014) Identification of expressed and conserved human noncoding RNAs. RNA 20:2, pages 236-251.
Crossref
Young-Ae Park, Jeong-Won Lee, Hye-Sun Kim, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Jung-Joo Choi, Hye-Kyung Jeon, Young Jae Cho, Ji Yoon Ryu, Byoung-Gie Kim & Duk-Soo Bae. (2014) Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma. Clinical Cancer Research 20:3, pages 565-575.
Crossref
Gabriel Wcislo, Agnieszka Synowiec, Katarzyna Szarlej-Wcislo & Lubomir Bodnar. 2014. Polyphenols in Human Health and Disease. Polyphenols in Human Health and Disease 1257 1268 .
Vanessa M. Peterson, Cesar M. Castro, Jaehoon ChungNathan C. Miller, Adeeti V. Ullal, Maria D. CastanoRichard T. Penson, Hakho LeeMichael J. Birrer & Ralph Weissleder. (2013) Ascites analysis by a microfluidic chip allows tumor-cell profiling. Proceedings of the National Academy of Sciences 110:51.
Crossref
Hong Zheng, Lina Zhang, Yanrui Zhao, Da Yang, Fengju Song, Yang Wen, Quan Hao, Zhibin Hu, Wei Zhang & Kexin Chen. (2013) Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer. PLoS ONE 8:11, pages e77853.
Crossref
Nadine Alaa, Amr Wahba, Sherif Negm, Amal Hanfy, Manal Kamal & Yasser Shabaan. (2013) The use of human epididymis protein 4 for differentiation between benign and malignant ovarian neoplasm. Evidence Based Womenʼs Health Journal 3:4, pages 173-177.
Crossref
Noriaki Arakawa, Etsuko Miyagi, Ayako Nomura, Erina Morita, Yoko Ino, Norihisa Ohtake, Yohei Miyagi, Fumiki Hirahara & Hisashi Hirano. (2013) Secretome-Based Identification of TFPI2, A Novel Serum Biomarker for Detection of Ovarian Clear Cell Adenocarcinoma. Journal of Proteome Research 12:10, pages 4340-4350.
Crossref
Iulia Diaconu, Cecilia Cristea, Veronica Hârceagă, Giovanna Marrazza, Ioana Berindan-Neagoe & Robert Săndulescu. (2013) Electrochemical immunosensors in breast and ovarian cancer. Clinica Chimica Acta 425, pages 128-138.
Crossref
Minoo Robati, Abbas Ghaderi, Mitra Mehraban, Amin Shafizad, Hamid Nasrolahi & Mohammad Mohammadianpanah. (2013) Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts. Archives of Gynecology and Obstetrics 288:4, pages 859-865.
Crossref
Carolyn Rooth. (2013) Ovarian cancer: risk factors, treatment and management. British Journal of Nursing 22:Sup17, pages S23-S30.
Crossref
Ali Amirkhosravi, Glenn Bigsby, Hina Desai, Mildred Rivera-Amaya, Enriqueta Coll, Liza Robles-Carrillo, Patricia Faust, Alane Waters, Todd Meyer, Enriquo Reyes, Florian Langer & John L. Francis. (2013) Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses. Blood Coagulation & Fibrinolysis 24:5, pages 510-517.
Crossref
Heath A. Huckabay, Sarah M. Wildgen & Robert C. Dunn. (2013) Label-free detection of ovarian cancer biomarkers using whispering gallery mode imaging. Biosensors and Bioelectronics 45, pages 223-229.
Crossref
Amal Z. Azzam, Doaa I. Hashad & Nahla A. F. Kamel. (2013) Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?. Archives of Gynecology and Obstetrics 288:1, pages 167-172.
Crossref
JU HEE KIM, YONG-WAN KIM, IN-WOOK KIM, DONG CHUN PARK, YONG WOOK KIM, KEUN-HO LEE, CHUN KEUN JANG & WOONG SHICK AHN. (2013) Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients. International Journal of Oncology 42:4, pages 1257-1262.
Crossref
R. Falzarano, V. Viggiani, S. Michienzi, B. Colaprisca, F. Longo, L. Frati & E. Anastasi. (2012) CLEIA CA125 evidences: good analytical performance avoiding “Hook effect”. Tumor Biology 34:1, pages 387-393.
Crossref
Dominic Varga, Miriam Deniz, Lukas Schwentner & Lisa Wiesmüller. (2013) Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects. International Journal of Molecular Sciences 14:1, pages 640-673.
Crossref
Huan-Chieh Cho, Chien- Huang Liao, Alice L Yu & John Yu. (2018) Surface markers in stem cells and cancer from the perspective of glycomic analysis. The International Journal of Biological Markers 27:4, pages 344-352.
Crossref
Peter E SchwartzGang YeStefanie BernaudoChun Peng. 2012. Advances in Ovarian Cancer Management. Advances in Ovarian Cancer Management 6 16 .
Sreeja Sarojini, Ayala Tamir, Heejin Lim, Shihong Li, Shifang Zhang, Andre Goy, Andrew Pecora & K. Stephen Suh. (2012) Early Detection Biomarkers for Ovarian Cancer. Journal of Oncology 2012, pages 1-15.
Crossref
Frank A. Alexander Jr, Eric G. Huey, Dorielle T. Price & Shekhar Bhansali. (2012) Real-time impedance analysis of silica nanowire toxicity on epithelial breast cancer cells. The Analyst 137:24, pages 5823.
Crossref
L Gao, HY Cheng, L Dong, X Ye, YN Liu, XH Chang, YX Cheng, J Chen, RQ Ma & H Cui. (2011) The Role of HE4 in Ovarian Cancer: Inhibiting Tumour Cell Proliferation and Metastasis. Journal of International Medical Research 39:5, pages 1645-1660.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.